Literature DB >> 22592119

Apolipoprotein B secretory regulation by degradation.

Sven-Olof Olofsson1, Jan Borén.   

Abstract

In this short review, we discuss apolipoprotein B100 and the assembly of very low-density lipoproteins. In particular, we address the nature and importance of co- and posttranslational degradation of apolipoprotein B100 during the assembly process. We also provide a short historical background to the development of the current model for the degradation of apolipoprotein B100.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22592119     DOI: 10.1161/ATVBAHA.112.251116

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  21 in total

Review 1.  Can modulators of apolipoproteinB biogenesis serve as an alternate target for cholesterol-lowering drugs?

Authors:  Lynley M Doonan; Edward A Fisher; Jeffrey L Brodsky
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2018-04-06       Impact factor: 4.698

2.  Control of very low-density lipoprotein secretion by N-ethylmaleimide-sensitive factor and miR-33.

Authors:  Ryan M Allen; Tyler J Marquart; Jordan J Jesse; Angel Baldán
Journal:  Circ Res       Date:  2014-04-21       Impact factor: 17.367

Review 3.  Biology of proprotein convertase subtilisin kexin 9: beyond low-density lipoprotein cholesterol lowering.

Authors:  Giuseppe Danilo Norata; Hagai Tavori; Angela Pirillo; Sergio Fazio; Alberico L Catapano
Journal:  Cardiovasc Res       Date:  2016-08-05       Impact factor: 10.787

Review 4.  Membrane Protein Quantity Control at the Endoplasmic Reticulum.

Authors:  Ignat Printsev; Daniel Curiel; Kermit L Carraway
Journal:  J Membr Biol       Date:  2016-10-14       Impact factor: 1.843

Review 5.  Regression of Atherosclerosis: The Journey From the Liver to the Plaque and Back.

Authors:  Edward A Fisher
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-12-17       Impact factor: 8.311

Review 6.  The unfolded protein response and hepatic lipid metabolism in non alcoholic fatty liver disease.

Authors:  Myeong Jun Song; Harmeet Malhi
Journal:  Pharmacol Ther       Date:  2019-08-13       Impact factor: 12.310

Review 7.  On the function and homeostasis of PCSK9: reciprocal interaction with LDLR and additional lipid effects.

Authors:  Hagai Tavori; Shirya Rashid; Sergio Fazio
Journal:  Atherosclerosis       Date:  2014-12-17       Impact factor: 5.162

8.  Mature VLDL triggers the biogenesis of a distinct vesicle from the trans-Golgi network for its export to the plasma membrane.

Authors:  Tanvir Hossain; Aladdin Riad; Shaila Siddiqi; Sampath Parthasarathy; Shadab A Siddiqi
Journal:  Biochem J       Date:  2014-04-01       Impact factor: 3.857

Review 9.  Hyperlipoproteinemia type 3: the forgotten phenotype.

Authors:  Paul N Hopkins; Eliot A Brinton; M Nazeem Nanjee
Journal:  Curr Atheroscler Rep       Date:  2014-09       Impact factor: 5.113

10.  Nuclear envelope-localized torsinA-LAP1 complex regulates hepatic VLDL secretion and steatosis.

Authors:  Ji-Yeon Shin; Antonio Hernandez-Ono; Tatyana Fedotova; Cecilia Östlund; Michael J Lee; Sarah B Gibeley; Chun-Chi Liang; William T Dauer; Henry N Ginsberg; Howard J Worman
Journal:  J Clin Invest       Date:  2019-08-13       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.